S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NASDAQ:AKAM

Akamai Technologies - AKAM Insider Trading & Ownership

$76.37
+0.32 (+0.42%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$76.02
▼
$76.94
50-Day Range
$70.75
▼
$91.28
52-Week Range
$70.65
▼
$123.25
Volume
1.42 million shs
Average Volume
1.74 million shs
Market Capitalization
$11.94 billion
P/E Ratio
25.71
Dividend Yield
N/A
Price Target
$100.63

Akamai Technologies (NASDAQ:AKAM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.70%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$751,185.81
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$8.65 M

AKAM Insider Buying and Selling by Quarter

Get AKAM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akamai Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Akamai Technologies Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/24/2023F Thomson LeightonCEOBuy333$75.18$25,034.9475,951  
3/22/2023F Thomson LeightonCEOBuy332$75.49$25,062.6875,283  
3/20/2023F Thomson LeightonCEOBuy341$73.38$25,022.5874,618  
3/17/2023F Thomson LeightonCEOBuy343$72.89$25,001.2774,277  
3/15/2023F Thomson LeightonCEOBuy350$71.53$25,035.5073,586  
3/15/2023Robert BlumofeCTOSell4,000$72.08$288,320.0029,716  
3/14/2023Anthony P WilliamsEVPSell6,300$71.23$448,749.0013,992  
3/13/2023Edward J McgowanCFOSell2,469$71.71$177,051.9926,677  
3/13/2023F Thomson LeightonCEOBuy349$71.78$25,051.2272,887  
3/10/2023Aaron AholaEVPSell1,514$73.39$111,112.4616,284  
3/9/2023Edward J McgowanCFOSell2,043$74.42$152,040.0629,146  
3/9/2023F Thomson LeightonCEOBuy336$74.44$25,011.8472,198  
3/8/2023Aaron AholaEVPSell3,471$74.76$259,491.9617,798  
3/7/2023Edward J McgowanCFOSell2,320$75.28$174,649.6028,720  
3/7/2023F Thomson LeightonCEOBuy333$75.28$25,068.2464,942  
2/27/2023F Thomson LeightonCEOBuy342$73.22$25,041.2448,909  
2/24/2023F Thomson LeightonCEOBuy337$74.27$25,028.9948,567  
2/21/2023F Thomson LeightonCEOBuy325$76.99$25,021.7512,431  
2/10/2023F Thomson LeightonCEOBuy290$86.26$25,015.4012,106  
2/8/2023F Thomson LeightonCEOBuy284$88.14$25,031.7611,528  
2/6/2023F Thomson LeightonCEOBuy282$88.73$25,021.8610,958  
2/2/2023Adam KaronCOOSell10,500$90.00$945,000.0021,389  
1/31/2023Paul C JosephEVPSell1,500$87.47$131,205.0025,306  
1/30/2023F Thomson LeightonCEOBuy287$87.36$25,072.329,549  
1/27/2023F Thomson LeightonCEOBuy286$87.44$25,007.849,262  
1/25/2023F Thomson LeightonCEOBuy287$87.20$25,026.408,690  
1/23/2023F Thomson LeightonCEOBuy285$87.99$25,077.158,117  
1/19/2023F Thomson LeightonCEOBuy285$87.88$25,045.807,543  
1/17/2023F Thomson LeightonCEOBuy282$88.86$25,058.526,979  
1/13/2023F Thomson LeightonCEOBuy283$88.50$25,045.506,697  
1/11/2023F Thomson LeightonCEOBuy285$87.96$25,068.606,132  
1/10/2023Mani SundaramEVPSell123$86.42$10,629.665,659  
1/5/2023F Thomson LeightonCEOBuy293$85.50$25,051.504,974  
1/3/2023F Thomson LeightonCEOBuy295$84.98$25,069.104,389  
1/3/2023Paul C JosephEVPSell1,500$85.00$127,500.0026,806  
12/29/2022F Thomson LeightonCEOBuy298$83.97$25,023.063,798  
12/27/2022F Thomson LeightonCEOBuy302$83.03$25,075.063,200  
12/19/2022F Thomson LeightonCEOBuy294$85.07$25,010.581,701  
12/16/2022F Thomson LeightonCEOBuy294$85.11$25,022.341,407  
12/14/2022F Thomson LeightonCEOBuy279$89.85$25,068.15828  
12/12/2022Aaron AholaEVPSell2,240$89.97$201,532.809,676  
12/12/2022F Thomson LeightonCEOBuy281$89.02$25,014.62281  
12/1/2022Paul C JosephEVPSell1,500$95.00$142,500.0028,306  
11/11/2022Robert BlumofeCTOSell5,000$92.92$464,600.009,835  
10/3/2022Paul C JosephEVPSell1,500$80.79$121,185.0031,183  
8/12/2022Robert BlumofeCTOSell5,000$94.25$471,250.0014,835  
5/13/2022Robert BlumofeCTOSell5,000$97.68$488,400.0019,725  
5/10/2022Paul C JosephEVPSell12,500$95.22$1,190,250.0032,573  
4/11/2022Mani SundaramEVPSell16,059$117.92$1,893,677.28  
4/8/2022Robert BlumofeCTOSell3,308$119.19$394,280.5224,725  
3/29/2022Edward J McgowanCFOSell3,805$120.00$456,600.00  
(Data available from 1/1/2013 forward)












AKAM Insider Trading Activity - Frequently Asked Questions

Who is on Akamai Technologies's Insider Roster?

The list of insiders at Akamai Technologies includes Aaron Ahola, Adam Karon, Anthony P Williams, Bernardus Johannes M Verwaayen, Edward J Mcgowan, F Thomson Leighton, Kim Salem-Jackson, Madhu Ranganathan, Mani Sundaram, Monte E Ford, Paul C Joseph, Rick M Mcconnell, and Robert Blumofe. Learn more on insiders at AKAM.

What percentage of Akamai Technologies stock is owned by insiders?

1.70% of Akamai Technologies stock is owned by insiders. Learn more on AKAM's insider holdings.

Which Akamai Technologies insiders have been buying company stock?

The following insiders have purchased AKAM shares in the last 24 months: Aaron Ahola ($222.08), and F Thomson Leighton ($751,185.81).

How much insider buying is happening at Akamai Technologies?

Insiders have purchased a total of 9,195 AKAM shares in the last 24 months for a total of $751,407.89 bought.

Which Akamai Technologies insiders have been selling company stock?

The following insiders have sold AKAM shares in the last 24 months: Aaron Ahola ($740,917.22), Adam Karon ($2,560,950.00), Anthony P Williams ($999,806.88), Bernardus Johannes M Verwaayen ($877,060.00), Edward J Mcgowan ($2,853,460.49), Kim Salem-Jackson ($319,209.12), Mani Sundaram ($2,124,326.94), Monte E Ford ($1,120,119.50), Paul C Joseph ($1,712,640.00), Rick M Mcconnell ($1,530,621.68), and Robert Blumofe ($5,654,670.52).

How much insider selling is happening at Akamai Technologies?

Insiders have sold a total of 215,398 Akamai Technologies shares in the last 24 months for a total of $22,572,058.35 sold.

This page (NASDAQ:AKAM) was last updated on 3/28/2023 by MarketBeat.com Staff